A prospective, registry based, observational study to asses maternal, fetal and infant outcomes following exposure to lasmiditan First published 05/01/2022 Last updated 21/03/2024 EU PAS number:EUPAS44973 Study Ongoing
Syneos Health United Kingdom First published:23/04/2015 Last updated 06/03/2024 Institution Non-Pharmaceutical company ENCePP partner